Loading
VI
Valhi Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 12 Mar 2025.
Valhi Inc: what insiders have been doing
Valhi Inc, classified in the Chemicals & Materials sector, is a listed company based in Dallas, United States, founded in 1987. Its insiders report their share dealings to SEC (Form 4). Between 18 October 2025 and 18 October 2026, 1 insider published 1 filing.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 1 filing in twelve months, the company is quieter than the median of 19 filings across the 5,816 companies we follow on the same exchange. Over the whole record (from 2016), the tally stands at 3 purchases and no sales.
No insider has bought Valhi Inc shares on the open market in the past twelve months.
Other companies in the same sector with recent insider buying flagged by our signals: Culp Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
33
Thresholds
n/a
Buy Volume
€26,862
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleBryan A. Hanley1 buy
Since the insiders bought
- -21.8%Entry US$17.33 · Close at T+365 US$13.56
- -36.2%Entry US$23.38 · Close at T+365 US$14.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,274 of 24,148 companies
19.6
score / 100
Value22
Quality18
FCF yld-16%
Earn yld-11%
EV/EBITDA13.9x
ROE-3.0%
Gross mgn14%
Net mgn-2.8%
Debt/EBITDA7.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$18.04
Analyst consensus
Income statement
RevenueUS$2.1B
Gross profitUS$295.4M14% margin
EBITDAUS$80.5M4% margin
Net income-US$57.6M-2.4% margin
Valuation
P/Book0.5x
Beta0.98
Balance sheet & cash
Market capUS$510.9M
Total debtUS$611.6M
Free Cash Flow-US$82.1M
Debt / Equity43%
Profitability & ownership
ROE-3.0%
ROA0.4%
% insiders91.5%
% institutions4.2%
Last declaration on 22 May 2026
Declarations33 total
3,150 shares@ US$12.660.0089% mcap66.3% of flowCommon Stock $0.01 par value per shareSEC:0001188336-26-000004:0
1,250 shares@ US$15.74100.0% of flowCommon stock, $0.01 par value per shareSEC:0001062993-25-010185:0
1,250 shares@ US$15.74100.0% of flowCommon stock, $0.01 par value per shareSEC:0001062993-25-010193:0
1,250 shares@ US$15.74100.0% of flowCommon stock, $0.01 par value per shareSEC:0001062993-25-010187:0
1,250 shares@ US$15.74100.0% of flowCommon stock, $0.01 par value per shareSEC:0001062993-25-010189:0
1,250 shares@ US$15.74100.0% of flowCommon Stock, $0.01 par value per shareSEC:0001062993-25-010194:0
1,250 shares@ US$15.7433.7% of flowCommon stock, $0.01 par value per shareSEC:0001062993-25-010184:0
250 shares@ US$17.50100.0% of flowCommon Stock, $0.01 par value per shareSEC:0001062993-25-005224:0
Canonical exit: 9 Jun 2025 (T+90)
1,050 sharesCommon stock, $0.01 par value per shareSEC:0001062993-24-011134:0
1,050 sharesCommon stock, $0.01 par value per shareSEC:0001062993-24-011137:0
1,050 sharesCommon Stock, $0.01 par value per shareSEC:0001062993-24-011129:0
1,050 sharesCommon stock, $0.01 par value per shareSEC:0001062993-24-011131:0
1,050 sharesCommon stock, $0.01 par value per shareSEC:0001062993-24-011139:0
1,050 sharesCommon stock, $0.01 par value per shareSEC:0001062993-24-011127:0
1,500 sharesCommon stock, $0.01 par value per shareSEC:0001062993-23-012252:0
1,500 sharesCommon stock, $0.01 par value per shareSEC:0001062993-23-012254:0
1,500 sharesCommon stock, $0.01 par value per shareSEC:0001062993-23-012262:0
1,500 sharesCommon Stock, $0.01 par value per shareSEC:0001062993-23-012256:0
1,500 sharesCommon stock, $0.01 par value per shareSEC:0001062993-23-012258:0
1,500 sharesCommon stock, $0.01 par value per shareSEC:0001062993-23-012260:0
1,000 shares@ US$23.96100.0% of flowCommon Stock, $0.01 par value per shareSEC:0001062993-22-023438:0
Canonical exit: 6 Mar 2023 (T+90)
400 sharesCommon Stock, $0.01 par value per shareSEC:0001062993-22-013638:0
400 sharesCommon stock, $0.01 par value per shareSEC:0001062993-22-013634:0
400 sharesCommon stock, $0.01 par value per shareSEC:0001062993-22-013632:0
400 sharesCommon stock, $0.01 par value per shareSEC:0001062993-22-013630:0
25 of 33 declarations
About Valhi Inc
Valhi, Inc. (NYSE: VHI) is a US-listed industrial holding company headquartered in Dallas, Texas, in the United States. For European investors, Valhi is best viewed as a diversified, control-influenced conglomerate with exposure to cyclical industrial materials, niche component manufacturing, and real estate development. Its equity story is driven less by a single operating brand and more by the performance of its major subsidiaries and the commodity/industrial cycle, especially titanium dioxide (TiO2).
Valhi’s corporate roots go back to the Contran-controlled group of companies, and the company’s current corporate structure was formed in 1987 through a merger involving Contran-related entities. That history still matters today because it shapes the group’s ownership profile and governance model. Valhi describes itself as operating through majority-owned subsidiaries and, in some cases, less-than-majority-owned affiliates, which makes it a holding company rather than a pure-play manufacturer. The company is listed on the NYSE, and its operations are based in the United States.
Read moreShow less
Valhi’s business is organized into three core segments. The Chemicals segment is the largest and most economically important. It manufactures and sells TiO2 pigments, a key input used in coatings, paints, plastics, paper, and other applications where whiteness, opacity, and durability matter. This segment is the main revenue engine, but it is also the most cyclical and volatile because profitability depends on TiO2 pricing, plant utilization, raw material costs, foreign exchange, and global supply-demand balances. The Component Products segment includes security products and recreational marine components, serving markets such as government security, industrial customers, and towboat-related end markets. The Real Estate Management and Development segment focuses on land development and related real estate activities, providing a smaller but strategically useful source of earnings and asset value.
From a competitive standpoint, Valhi operates in specialized, highly competitive niches. In chemicals, it competes with global TiO2 producers in an industry that is sensitive to capacity utilization, pricing discipline, and regional demand trends. In component products, the company has a more focused niche position, with products tailored to security and marine applications rather than broad commodity manufacturing. The real estate segment is more opportunistic and asset-driven than volume-driven.
Recent developments underscore the cyclical nature of the group. In March 2026, Valhi reported full-year 2025 results showing a net loss attributable to Valhi stockholders, largely because the Chemicals segment faced lower average TiO2 selling prices, reduced operating rates, unabsorbed fixed production costs, and restructuring-related charges. At the same time, Component Products improved year over year, with stronger sales and margins in security and marine components, and the real estate segment benefited from infrastructure tax increment reimbursements. The takeaway for investors is that Valhi remains a diversified industrial holding company whose earnings profile is highly sensitive to the global TiO2 cycle, manufacturing utilization, and the performance of its smaller non-chemicals businesses.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
